AKERO 106_Dinani - Clinical Trial
Who Can Participate in the Study?
Grupo etario
Adultos
Study Details
Full Title
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
EVALUATING THE SAFETY AND EFFICACY OF EFRUXIFERMIN IN SUBJECTS
WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)/METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
Principal Investigator
Especialista en hepatología
Protocol Number
IRB:
PRO00117203
NCT:
NCT06528314
Phase
Phase
III
ClinicalTrials.gov
View on ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción